Ponoi Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Ponoi Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$17M	Hold	1,298,908	–	–	23.2%	2
2022 Q2	$16.7M	Hold	1,298,908	–	–	26.29%	2
2022 Q1	$19.8M	Hold	1,298,908	–	–	25.71%	2
2021 Q4	$23M	Hold	1,298,908	–	–	21.21%	2
2021 Q3	$27.3M	Hold	1,298,908	–	–	24.24%	2
2021 Q2	$25.6M	Hold	1,298,908	–	–	14.23%	3
2021 Q1	$37.8M	Hold	1,298,908	–	–	22.21%	2
2020 Q4	$39.4M	Buy	+1,298,908	New	+$28.4M	22.52%	2

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return